13th Annual Clinical Trials Summit 2022 in Mumbai
From: 19 May 2022 To: 19 May 2022
Start Time: 09:00 AM End Time: 05:00 PM
Venue: Andheri Kurla Road, Andheri ( E ), Mumbai
Created By: Kavitha
Event Description
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">13th
Annual Clinical Trials Summit 2022
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">13th
Annual Clinical Trials Summit 2022
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">
color:#555555">
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">19th May 2022, Kohinoor Continental Hotel, Mumbai, Indiamajor-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial;color:#555555">
color:#555555">19th May 2022, Kohinoor Continental Hotel, Mumbai, Indiamajor-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">13th
Annual Clinical Trials Summit 2022 will provide a platform to discuss on the
futuristic advancements in clinical trials and clinical research. This multidisciplinary
program involves broad participation of people from clinical trials community
from around the globe who are focused on learning more about clinical research,
clinical trials planning and management.
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">13th
Annual Clinical Trials Summit 2022 will provide a platform to discuss on the
futuristic advancements in clinical trials and clinical research. This multidisciplinary
program involves broad participation of people from clinical trials community
from around the globe who are focused on learning more about clinical research,
clinical trials planning and management.
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">
color:#555555">
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">This conference intends to focus on the global health and
clinical trials around the world. Bioethics, regulations, patient recruitment,
site selection, real-world data, data integration & Strategy, outsourcing,
vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical
auditing & financial planning and other significant topics that play a key
role in clinical trials will be addressed along with innovative sessions on new
technologies, effective and quality collaborations.
color:#555555">This conference intends to focus on the global health and
clinical trials around the world. Bioethics, regulations, patient recruitment,
site selection, real-world data, data integration & Strategy, outsourcing,
vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical
auditing & financial planning and other significant topics that play a key
role in clinical trials will be addressed along with innovative sessions on new
technologies, effective and quality collaborations.
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">
color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">SPONSORS:
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">SPONSORS:
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">
color:#555555">
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">Tenthpin, Clinevo Technologies, Advity Research, Ontime Globe
Kyarrier, Innvocept Solutions, Target Institute Of Medical Education &
Research, Zuellig Pharma, Chitkara University
color:#555555">Tenthpin, Clinevo Technologies, Advity Research, Ontime Globe
Kyarrier, Innvocept Solutions, Target Institute Of Medical Education &
Research, Zuellig Pharma, Chitkara University
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">DELEGATE
REGISTRATION:mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">DELEGATE
REGISTRATION:mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">E-mail
– mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-latin;
mso-bidi-font-family:Arial">kavitha@virtueinsight.co.inmajor-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial;color:#555555"> or Call - + 91 44 24762472/ +91 9361957193
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">E-mail
– mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-latin;
mso-bidi-font-family:Arial">kavitha@virtueinsight.co.inmajor-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial;color:#555555"> or Call - + 91 44 24762472/ +91 9361957193
- mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Standard
Price - (INR 15,000 + GST (18%) per delegate)
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Conference
Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest
and queriesmso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Conference
Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest
and queriesmso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">KEY
SPEAKERS:mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">KEY
SPEAKERS:mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
- mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">KAMAL K
HALDER, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial"> ADCI, CDSCO
(WZ) - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">MUKESH KUMAR, major-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial">Senior Vice President & Head,
Clinical R&D, Cipla - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SADHNA
JOGLEKAR, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Senior Vice
President, Global Medical Affairs, Sun Pharma - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">PRATIK
SHAH, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Vice
President Medical Affairs, Bharat Serums and Vaccines - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">RAVI SEKHAR
KASIBHATTA, "Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:
Arial">Senior Vice President, Clinical Research, Lupin - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">MANISH
SHAH, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
Vice President, Wockhardt - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SANDESH
SAWANT, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Senior
Director, Medical Services Head - Clinical Trials, Cipla - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">RAGHURAM
JANAPAREDDY, "Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:
Arial">Partner & Managing Director – India, Tenthpin - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">DIVAKAR
KOLLI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
Director and Head - Clinical & Non-Clinical QA, Cipla - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">TUSHAR
SAKPAL, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Director -
Clinical Data Standards & Automation, Novartis - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">MILIND
ANTANI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Leader,
Pharma and Healthcare, Nishith Desai Associates - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">YASMIN
SHENOY, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Director-Regulatory
Affairs, Sanofi - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ANIKET
JOSHI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
Global Portfolio Delivery Director, Novartis - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">RISHI
JAIN, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Medical
Director, AbbVie - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">DILIP
PAWAR, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head -
Medical Affairs and Pharmacovigilance, Unichem Laboratories - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">CHIRAG
TRIVEDI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Clinical
Study Unit Cluster Head, Sanofi - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">KEDAR
NAYAK, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head -
Clinical Development, GSK - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ARUN
BHATT, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Consultant –
Clinical Research & Development - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">AMITA
BHAVE, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head
Regulatory Affairs GDD, Novartis - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">HARSHAD
KOTHAWADE, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head-Regulatory
Management & Trade Compliance, Merck - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SADANAND
KULKARNI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head-Medical,
Regulatory, Vigilance, Quality, Fresenius Kabi - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">VAIBHAV
SALVI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head –
Medical Information, Asia, Sanofi - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">INDRANIL
PURKAIT, S mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">r. General
Manager and Head Medical Affairs, Ipca Laboratories - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ASHWANI
PANDITA , mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">General
Manager Quality Management & Training, Global Clinical Research Operations, Glenmark - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">VALLABH
DESHPANDE, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">HOD PV
Operations, Glenmark - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">VISHWAS
SOVANI, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Founder
Director, Pharmawisdom - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">GANESH
KADHE, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Senior
Leadership Team Member, Scientific & Medical Affairs, Abbott
Nutrition - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SAKHARAM
GARALE, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Founder &
CEO, Renovare Healthcare Solutions - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ROSHAN
PAWAR, mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
General Manager, Alkem Laboratories
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Plus
more joining soon
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Plus
more joining soon
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">KEY
THEMES DISCUSSED:mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">KEY
THEMES DISCUSSED:mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
- mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">The growth of
hybrid trial and virtual trials in India – Where we are? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Better
patient recruitment and retention – Can be achieved by DCT? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Digital
transformation and AI in clinical trials - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">What are key
challenges in patient safety? Ways to overcome and better alternatives - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Risk-based
monitoring (RBM) – Is ensuring patient safety? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Clinical
trial design and implementation – How technology makes an easier way? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Wearable
devices, remote monitoring and virtual trials – Risk and benefits - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Key market
trends and challenges driving opportunities and outsourcing - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">End-to-end
strategic partnership and managing the communications gap in CROs - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">How can
sponsors successfully manage the EU CTR change? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Technology
accelerates new age clinical research - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Are the
regulations sufficient in clinical trials and what needs to be done? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Remote
clinical research – Risks and chances - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">How RWE is
transforming clinical trials? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">How do we
deal with privacy concerns around RWD? - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Ensuring and
maintaining compliance with the rules and regulations. - mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Be part of a
major networking opportunity
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">WHO
SHOULD ATTEND AND WHO YOU’LL MEET:"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">WHO
SHOULD ATTEND AND WHO YOU’LL MEET:"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">CIOs,
CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from
the following areas:
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">CIOs,
CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from
the following areas:
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Clinical
Research & Development, Clinical Research Services, Clinical Operations,
Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs,
Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study
Design, Safety Surveillance, Subject Recruitment, E-Clinical System
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Clinical
Research & Development, Clinical Research Services, Clinical Operations,
Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs,
Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study
Design, Safety Surveillance, Subject Recruitment, E-Clinical System
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Get
more from the event, with a broader scope bringing the whole communications
value chain together. Enjoy and make the best out of our dedicated networking
time, meet the leading international vendors showcasing the products of
tomorrow in the co-located exhibition. Expand your knowledge of the latest
business models and strategies in the high-level conference.
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Get
more from the event, with a broader scope bringing the whole communications
value chain together. Enjoy and make the best out of our dedicated networking
time, meet the leading international vendors showcasing the products of
tomorrow in the co-located exhibition. Expand your knowledge of the latest
business models and strategies in the high-level conference.
major-latin;mso-hansi-theme-font:major-latin">
Share This Event
Total Event Views = 46
_thumb.jpg)
